CAI Yun, SHE Yuanxia, LIU Shu. Expression and clinical significance of epithelial cell adhesion factor and tumor associated glycoprotein-72 in colon cancer[J]. Journal of Clinical Medicine in Practice, 2019, 23(21): 37-40. DOI: 10.7619/jcmp.201921011
Citation: CAI Yun, SHE Yuanxia, LIU Shu. Expression and clinical significance of epithelial cell adhesion factor and tumor associated glycoprotein-72 in colon cancer[J]. Journal of Clinical Medicine in Practice, 2019, 23(21): 37-40. DOI: 10.7619/jcmp.201921011

Expression and clinical significance of epithelial cell adhesion factor and tumor associated glycoprotein-72 in colon cancer

More Information
  • Received Date: July 23, 2019
  • Available Online: February 28, 2021
  • Published Date: November 14, 2019
  •   Objective  To investigate the expression and clinical significance of epithelial cell adhesion factor (EpCAM) and tumor associated glycoprotein-72 (TAG-72) in colon cancer.
      Methods  Expressions of EpCAM and TAG-72 in 132 cases of colon cancer was detected by immunohistochemistry, and the scores were calculated. The relationship between the expression of EpCAM, TAG-72 and the clinicopathological characteristics, prognosis was analyzed.
      Results  The positive rate of EpCAM was 65.91%, with an average score of (2.48±0.54) points. The positive rate of TAG-72 was 70.45%, with an average score of (2.56±0.62) points. The positive rate of EpCAM and TAG-72 was 58.33%, with an average score of (3.12±0.60) points. The positive rates of EpCAM, TAG-72 and scores were significantly higher in patients with pathological characteristics such as tumor diameter over 3 cm, low differentiation/mucociliary pancreas, TNM stage (stage Ⅲ to Ⅳ), T3~4 depth of invasion and lymph node metastasis than those with tumor diameter less or equal to 3 cm, high differentiation, TNM stage (stage Ⅰ to Ⅱ), T1~2 depth of invasion and no lymph node metastasis (P < 0.05 or P < 0.01). The scores of patients with positive EpCAM, positive TAG-72, positive EpCAM and positive TAG-72 expressions were significantly higher than those with negative expressions, and the survival time was significantly shorter than those with negative expressions (P < 0.01). The scores of patients with positive EpCAM and positive TAG-72 expression were significantly higher than those with only positive EpCAM or positive TAG-72 expressions (P < 0.01), and the survival time was significantly shorter than those with only positive EpCAM or positive TAG-72 expressions (P < 0.01).
      Conclusion  The expressions of EpCAM and TAG-72 are related to tumor diameter, differentiation degree, TNM stage, invasion depth and lymph node metastasis. The survival time of patients with positive EpCAM, TAG-72 expressions shorter significantly, and the prognosis of patients with positive expressions of both EpCAM and TAG-72 is worse.
  • [1]
    王锡山. 中美结直肠癌流行病学特征及防诊治策略的对比分析[J/CD]. 中华结肠疾病电子杂志, 2017, 6(6): 447-453. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHZC201706003.htm
    [2]
    Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132. doi: 10.3322/caac.21338
    [3]
    马敏星, 周瑞, 张嘉刚, 等. 结直肠癌中CD44和上皮细胞黏附分子相关基因与通路的生物信息学研究[J]. 中华消化杂志, 2016, 36(3): 182-187. doi: 10.3760/cma.j.issn.0254-1432.2016.03.008
    [4]
    Wang A, Ramjeesingh R, Chen C H, et al. Reduction in membranous immunohistochemical staining for the intracellular domain of epithelial cell adhesion molecule correlates with poor patient outcome in primary colorectal[J]. Curr Oncol, 2016, 23(3): e171-e178.
    [5]
    沙莎, 于波, 舒钟琴, 等. 放疗对食管磷癌患者血清SCC、CEA、CRFRA211、TAG72、CA199、T淋巴细胞亚群的影响[J]. 海南医学院学报, 2016, 22(17): 2003-2006, 2010. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYY201617022.htm
    [6]
    Cho J, Kim K M, Kim H C, et al. The prognostic role of tumor associated glycoprotein 72(TAG-72) in stage Ⅱ and Ⅲ colorectal adenocarcinoma[J]. Pathol Res Pract, 2019, 215(1): 171-176. doi: 10.1016/j.prp.2018.10.024
    [7]
    Courtney R J, Paul C L, Carey M L, et al. A population-based cross-sectional study of colorectal cancer screening practices of firs-degree relatives of colorectal cancer patients[J]. BMC Cancer, 2013, 13(1): 1-11. doi: 10.1186/1471-2407-13-1
    [8]
    Chai X B, Song R F, Xu F. Expression changes in epithelial cell adhesion molecule during colorectal cancer tumorigenesis[J]. Genen Mol Res, 2015, 14(3): 7624-7629. doi: 10.4238/2015.July.13.6
    [9]
    涂雪松, 胡利霞, 瞿广桥, 等. 靶向下调上皮细胞黏附分子对结直肠癌干细胞功能及药物敏感性的影响[J]. 中国临床药理学杂志, 2018, 34(1): 34-37. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ201801009.htm
    [10]
    Isaeva A V, Zima A P, Shabalova I P, et al. β-Catenin: Structure, Function and Role in Malignant Transformation of Epithelial Cells[J]. Vestn Ross Akad Med Nauk, 2015, 4: 475-473. http://europepmc.org/abstract/MED/26710532
    [11]
    Kroepil F, Dulian A, Vallbohmer D, et al. High EpCAM expression is linked to proliferation and Lauren classification in gastric cancer [J/OL]. BMC Res Notes, 2013, 6: 253-259. doi: 10.1186/1756-0500-6-253
    [12]
    周逢强, 齐艳美, 高雪杉, 等. 上皮细胞黏附因子在结直肠癌中的表达与β-连环蛋白的关系及其临床意义[J]. 中华实验外科杂志, 2013, 30(7): 1517-1519. doi: 10.3760/cma.j.issn.1001-9030.2013.07.064
    [13]
    Gong L, Ding H, Long N E, et al. A 3E8. scFv. Cys-IR800 Conjugate Targeting TAG-72 in an Orthotopic Colorectal Cancer Model[J]. Mol Imaging Biol, 2018, 20(1): 47-54. doi: 10.1007/s11307-017-1096-4
    [14]
    Chien M H, Chang W M, Lee W J, et al. A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio[J]. Mol Cancer Ther, 2017, 16(6): 1102-1113. doi: 10.1158/1535-7163.MCT-16-0314
    [15]
    柴晓菲, 刘明阁, 宋魏, 等. TAG-72在卵巢癌组织中的表达及意义[J]. 中国实用医药, 2016, 11(17): 36-37. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSSA201617017.htm
    [16]
    Lee S H, Jeung I C, Park T W, et al. Extension of the in vivo half-life of endostatin and its improved anti-tumor activities upon fusion to a humanized antibody against tumor-associated glycoprotein 72 in a mouse model of human colorectal carcinoma[J]. Oncotarget, 2015, 6(9): 7182-7194. doi: 10.18632/oncotarget.3121
    [17]
    陈红, 谢燕, 黄晓楠. 肿瘤相关糖蛋白-72在结肠癌及癌前病变组织中的表达[J]. 诊断病理学杂志, 2010, 17(6): 444-447. doi: 10.3969/j.issn.1007-8096.2010.06.015
    [18]
    张宁, 李小丽, 李格林. 等. AEG-1和LEF-1在人结肠癌组织中的表达及其意义[J]. 实用医学杂志, 2015(7): 1160-1162. doi: 10.3969/j.issn.1006-5725.2015.07.039
    [19]
    姜维民, 徐小永, 杨捷, 等. 结直肠癌组织AEG-1/MTDH表达Meta分析[J]. 中华肿瘤防治杂志, 2016, 23(8): 537-543. https://www.cnki.com.cn/Article/CJFDTOTAL-QLZL201608016.htm
    [20]
    SU ZAOZHONG, KANG DONGCHUL, CHEN YINMING, et al. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH[J]. Oncogene, 2002, 22(22): 3592-3602. http://new.med.wanfangdata.com.cn/Paper/Detail?id=PeriodicalPaper_JJ0210545511
    [21]
    赵加应, 蔡元坤, 李小静, 等. 液泡膜-ATP酶与P-糖蛋白在结肠癌组织中的表达及其临床意义[J]. 中华普通外科杂志, 2014, 29(10): 771-774. doi: 10.3760/cma.j.issn.1007-631X.2014.10.010
  • Cited by

    Periodical cited type(17)

    1. 杨志国. 微创拔牙术治疗下颌低位阻生智齿的有效性及作用研究. 罕少疾病杂志. 2025(03): 40-42 .
    2. 金苏菊,李雪晶,刘凤林,朱晓洁. 规范化循证护理干预联合四手操作配合在下颌水平低位阻生智齿拔除术中的应用. 齐鲁护理杂志. 2024(06): 152-154 .
    3. 周芳,曾文玲. 循证护理联合规范化疼痛护理在低位阻生智齿拔除中的应用效果. 医疗装备. 2024(06): 123-125 .
    4. 吴康,王国栋. 微创拔牙术拔除下颌低位阻生智齿对疼痛程度的影响. 中国卫生标准管理. 2024(09): 123-127 .
    5. 方首镕,王晓云,雷雨露,宁润来,蒋宁宁. 下颌低位阻生智齿拔除应用CBCT介导超声骨刀的效果及对PTX3、MPO、PGE2的影响. 中国医学工程. 2023(02): 59-63 .
    6. 潘其达. 不翻瓣法配合涡轮机拔除下颌阻生智齿的应用效果及预后观察. 现代诊断与治疗. 2023(03): 428-430 .
    7. 王鑫,侍泉华. 浓缩生长因子在下颌阻生齿拔除术中的应用效果及对患者生活质量的影响. 中国美容医学. 2023(05): 142-145 .
    8. 王军,刘素芳,王会敏. 微创拔牙术治疗下颌复杂阻生牙的临床疗效. 深圳中西医结合杂志. 2023(08): 115-118 .
    9. 许慧英. 微创拔牙术在下颌阻生智齿拔除治疗中的应用及对患者拔牙后张口受限程度以及并发症情况的影响. 系统医学. 2023(08): 169-173 .
    10. 徐金伟,张琴,陈海苏,于保军,俞辉明. 高速涡轮钻联合超声骨刀对下颌低位阻生智齿拔除的效果. 中国医药导报. 2023(21): 129-132 .
    11. 杨剑. 微创拔牙器械配合高速涡轮牙钻拔牙法在下颌低位阻生智齿治疗中的效果评价. 中国医药科学. 2023(13): 195-198 .
    12. 邹雅琴,凌瑞,劳茉,王敬雯,栗璞. 微创拔牙术在下颌阻生智齿拔除中的应用价值. 实用临床医学. 2023(03): 74-77 .
    13. 张莉,闫召民,姚燕,王宇. 高速涡轮机联合微创拔牙刀在下颌阻生智齿中的应用及对疼痛程度、并发症的影响分析. 黑龙江医学. 2023(19): 2313-2315 .
    14. 王笑梅. 高速涡轮牙钻联合微创拔牙刀在阻生智齿拔除术中的应用效果. 医学信息. 2023(21): 118-121 .
    15. 沈博文. 微创拔牙与传统器械拔牙治疗下颌阻生智齿的疗效对比分析. 现代医学与健康研究电子杂志. 2022(03): 7-9 .
    16. 孙辉,陈志方,王晓东. 下颌水平低位阻生齿拔除术治疗下颌阻生第三磨牙对患者牙周健康状况的影响. 湖南师范大学学报(医学版). 2022(04): 74-77 .
    17. 杜文斌,曹玮奇,姚国华,张帅,李尔涛,任辉. 十字形分牙法在下颌水平低位阻生齿拔除中的临床效果分析. 中国美容医学. 2021(12): 105-108 .

    Other cited types(0)

Catalog

    Article views (272) PDF downloads (10) Cited by(17)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return